Winston Kung
Chief Financial Officer; Director · 4 filings · Latest: Jun 11, 2026
ArriVent BioPharma, Inc.
Corbus Pharmaceuticals Holdings, Inc.
Janux Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRBP | Winston Kung | Director | Jun 10, 2026 | Sale | $7.91 | 2,026 | $16.0K | 12,140 |